gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex.

Source:http://linkedlifedata.com/resource/pubmed/id/7673355

Download in:

View as

General Info

PMID
7673355